+
Site Tour

Search

  • Patients who benefit

    Real-world evidence shows a significant relationship between degree of residual MR and survival after transcatheter mitral repair. Tendyne™ is an option for select MR patients who may benefit from…

  • Patients who benefit

    49% of patients with symptomatic severe MR were not operated due to age, co-morbidities, or impaired LV.5 If left untreated, MR initiates a cascade of events leading to death, with 1-year…

  • Guidelines

    © Abbott 2023. All rights reserved. 9-EH-5-14473-01 08-2023 Summary of current relevant international guidelines on the diagnosis of TR TR should be evaluated first by echocardiography. In…

  • Clinical Data

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  DISCOVER NEW CLINICAL DATA PRESENTED AT ESOC* New clinical datas have been…

  • Patients who benefit

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  The Amplatzer™ Talisman™ PFO Occluder is indicated for percutaneous transcatheter…

  • Key Features

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  ADVANCING THE GOLD STANDARD IN PFO CLOSURE For decades, interventional cardiologists…

  • AV Valves SUMMIT 2024

    ON DEMAND AV VALVES SUMMIT 2024 2nd global edition of the AtrioVentricular Valves Summit After the success of the first edition, the AV Valves Summit was back for the second edition in Berlin…

  • AV Valves SUMMIT 2023

    ON DEMAND AV VALVES SUMMIT 2023 1st global edition of the AtrioVentricular Valves Summit The inaugural edition of AV Valves Summit established a new platform for collaboration, exploration, and…

  • Overview

    FROM THE #1 COMPANY IN CONGENITAL OCCLUDERS1 The Amplatzer™ line not only pioneered structural heart defect occluder devices, it remains the leader in innovation and treatment worldwide. The…

  • Key Features

    Two Amplatzer™ ASD Closure Devices for Optimizing Patient Care Abbott offers two devices for percutaneous, transcatheter ASD closure. Amplatzer™ Septal Occluder The Amplatzer™ Septal Occluder,…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline